A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease.
Seung Joon ChoiSungjin YoonKyoung-Kon KimDoojin KimHye Eun LeeKwang Gi KimSeung Kak ShinIe Byung ParkSeong Min KimDae Ho Lee
Published in: Diabetes & metabolism journal (2024)
Our blood composite biomarker can be useful to distinguish progressive forms of NAFLD as an initial noninvasive test when MR-based tools are not available.